MicroRNA miR-378 Regulates Nephronectin Expression Modulating Osteoblast Differentiation by Targeting GalNT-7 Authors: Shireen Kahai, Shao-Chen Lee, Daniel Y. Lee, Jennifer Yang, Minhui Li, Chia-Hui Wang, Zide Jiang, Yaou Zhang, Chun Peng, Burton B. Yang Published: 2009, PLOS ONE DOI: 10.1371/journal.pone.0007535 ABSTRACT MicroRNAs (miRNAs) are small fragments of single-stranded RNA containing 18-24 nucleotides, and are generated from endogenous transcripts. MicroRNAs function in post-transcriptional gene silencing by targeting the 3′-untranslated region (UTR) of mRNAs, resulting in translational repression. We have developed a system to study the role of miRNAs in cell differentiation. We have found that one of the miRNAs tested in our system (miR-378, also called miR-378*) plays a role in modulating nephronectin-mediated differentiation in the osteoblastic cell line, MC3T3-E1. Nephronectin is an extracellular matrix protein, and we have demonstrated that its over-expression enhanced osteoblast differentiation and bone nodule formation. Furthermore, we found that the nephronectin 3′-untranslated region (3′UTR) contains a binding site for miR-378 . Stable transfection of MC3T3-E1 cells with miR-378 inhibited cell differentiation. MC3T3-E1 cells stably transfected with nephronectin exhibited higher rates of differentiation and nodule formation as compared with cells transfected with nephronectin containing the 3′UTR in the early stages of development, suggesting that endogenous miR-378 is present and active. However, in the later stages of MC3T3-E1 development, the differentiation rates were opposite, with higher rates of differentiation and nodule formation in the cells over-expressing the 3′UTR of nephronectin. This appeared to be the consequence of competition between nephronectin and UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7 or GalNT7) for miR-378 binding, resulting in increased GalNT7 activity, which in turn lead to increased nephronectin glycosylation and product secretion, thereby resulting in a higher rate of osteoblast differentiation. INTRODUCTION Over the past few years, microRNAs (miRNAs) have emerged as a prominent class of gene regulatory factors [1] . MiRNAs are single-stranded RNAs of 18–24 nucleotides in length, and are generated from endogenous transcripts producing hairpin structures by an RNase III-type enzyme [2] – [5] . miRNA functions as a regulator in gene silencing by partially complementing with the 3′-untranslated region (3′UTR) of target mRNAs, leading to translational repression [6] – [8] . By silencing various target mRNAs, miRNAs have key roles in various regulatory pathways. This involves cell proliferation [9] , [10] , division [11] , [12] , apoptosis [13] , [14] , cell differentiation [15] – [20] , tissue development [21] – [27] , tumor formation [28] – [43] , protein expression [44] – [46] , immuno-response [47] , and viral infection [48] – [51] . Although miRNAs have emerged as key regulators of gene expression, our understanding of the specific roles of miRNAs has been limited due to the difficulty in tracking the functions of a particular miRNA. Furthermore, since chemically synthetic miRNAs are easily degraded, it is impossible to obtain stable cell lines expressing miRNAs for long-term functional analysis in vitro and in vivo. Although expression of a large DNA fragment has made stable expression possible [52] , in many cases miRNAs are expressed as a cluster, making it difficult to distinguish the function of a particular miRNA from others. To allow long-term studies of miRNA functions in vitro and in vivo, we have developed an expression vector expressing two copies of pre-miRNAs, a green fluorescent protein (GFP) tracking unit, and an antibiotic selection marker [53] , [54] . This allows stable expression of double amounts of the miRNA of interest in cells for functional studies. Nephronectin was discovered in the developing mouse kidney as a novel ligand for the integrin α8β1. It is a 70–90 kDa secreted extracellular matrix protein that contains a putative signal peptide at the N-terminus, five epidermal growth factor (EGF)-like repeats (amino acids 57–250), an RGD sequence (amino acids 382–384), and a C-terminal MAM domain (amino acids 417–561). As nephronectin is expressed in a variety of tissues in the developing mouse embryo, we studied the role of nephronectin in bone development. We also examined the regulation of nephronectin expression by miR-378 and demonstrated that miR-378 up-regulated nephronectin expression, and enhanced nephronectin glycosylation and secretion via binding to the 3′UTR of nephronectin mRNA. Interaction of miR-378 with nephronectin 3′UTR arrested this miRNA and freed another miR-378 target GalNT7, an enzyme essential for nephronectin glycosylation. As a consequence, nephronectin glycosylation was enhanced and osteoblast differentiation was promoted. RESULTS To study the role of nephronectin during osteoblast development, we generated a nephronectin construct (Npnt). A leading peptide (LP) of chicken link protein was tagged at the N-terminal region, which contains the secretion signal and an epitope recognized by the monoclonal antibody 4B6 ( Fig. 1A ). The osteoblast cell line MC3T3-E1 was stably transfected with the nephronectin construct or an empty vector. Conditioned medium from each stable cell line was examined for expression and secretion of nephronectin by western blot using the 4B6 antibody ( Fig. 1B ). We analyzed the activity of alkaline phosphatase (ALP), a well known marker of commitment to the osteoblast lineage, in the nephronectin-transfected MC3T3-E1 cells and observed a significantly higher level of ALP expression in the cells over-expressing nephronectin as compared with the vector-transfected cells ( Fig. 1C ). Typical micrographs are provided to show cell morphology after staining (ALP activity seen as the red colour in the wells, Fig. 1D , upper panel). Using a different phase on the microscope, we could focus on only the cells exhibiting ALP activity due to their red staining ( Fig. 1D , lower panel). This allowed quantification of the stained cells. Our results indicated that over-expression of nephronectin promotes osteoblast differentiation. (A) A full-length nephronectin construct was generated containing the 5 EGF-like repeats, RGD domain, and the MAM domain. A leading peptide (LP) was tagged at the N-terminal region of the construct (Panel A). (B) After transfection, conditioned medium from two nephronectin- and one vector-transfected MC3T3-E1 clones was analyzed for stable expression and secretion of the full-length nephronectin protein by western blot, using the monoclonal antibody 4B6 which recognizes an epitope in the leading peptide. (C) Two nephronectin- and two vector-transfected MC3T3-E1 clones were grown for 10 days and stained for ALP expression. Multiple fields were examined for each construct, and stained cells were counted per field for a quantitative graphical representation. Over-expressing nephronectin (Npnt-1 and Npnt-2) enhanced ALP expression. (D) Typical micrographs of ALP expression in the two clones were taken using two different phases (top and bottom panels) of the microscope for better estimation of ALP activity. (E) Left, MC3T3-E1 cells stably transfected with an siRNA construct against nephronectin were grown in parallel with cells transfected with the empty vector for 10 days and then stained for ALP activity. Multiple fields were examined for each construct, and stained cells were counted per field for quantitative analysis. Inset shows the expression level of the nephronectin protein after transfection with the siRNA against nephronectin. Right, typical micrographs of ALP expression are shown. To determine the effect of endogenous nephronectin on MC3T3-E1 cell differentiation, we analyzed the effect of knocking down nephronectin expression on osteoblast differentiation. Cell lines stably transfected with a small interfering RNA (siRNA) plasmid targeting nephronectin (Npnt-siRNA), or with the GFP vector alone, were generated. The GFP- and Npnt-siRNA-expressing cells were cultured under nodule-inducing conditions and then stained for ALP expression to identify differentiating cells. We observed minimal ALP expression in the MC3T3-E1 cells over-expressing the siRNA as compared with the vector control ( Fig. 1E ). Our results indicated that down-regulation of endogenous nephronectin expression inhibited osteoblast differentiation. THE EFFECT OF NEPHRONECTIN 3′UTR ON OSTEOBLAST DIFFERENTIATION We then studied regulation of nephronectin expression by miRNAs, as miRNAs have been reported to play essential roles in cell differentiation. We generated a nephronectin expression construct with a fragment of the nephronectin 3′UTR ( Fig. 2A , Npnt+3′). MC3T3-E1 cells were transfected with the construct Npnt+3′ to generate stable cell lines. Conditioned medium was examined for expression and secretion of the ectopic nephronectin by western blot ( Fig. 2A ). MC3T3-E1 cells transfected with either the Npnt construct, the Npnt+3′ construct, or the GFP vector control were cultured for 6 days under nodule-inducing conditions, followed by staining for ALP activity to identify differentiating osteoblasts. Again, over-expression of nephronectin promoted osteoblast differentiation as seen by the significantly higher ALP staining as compared with the control cells ( Fig. 2B and C ). A much lower rate of osteoblast differentiation was observed in the cells expressing the Npnt+3′ construct (Npnt+3′-1 and Npnt+3′-2), thereby providing further evidence towards the post-transcriptional repression of nephronectin by endogenous miRNAs during osteoblast differentiation. (A) A nephronectin construct with a fragment of the nephronectin 3′UTR spanning the target sequence of miR-378 is shown (Npnt+3′). Cell lysate and conditioned medium from MC3T3-E1 cells stably transfected with Npnt+3′ were analyzed by western blot showing secretion of the product. (B) Cells transfected with the full-length nephronectin (Npnt-1 and Npnt-2), nephronectin containing the 3′UTR (Npnt+3′-1 and Npnt+3′-2), or with the control vector were grown for 10 days and stained for ALP expression. Multiple fields were examined for each construct, and stained cells were counted per field for quantitative analysis. (C) Typical micrographs of ALP expression are shown using two different phases (top and bottom panels) of the microscope. We then investigated the effect of over-expressing the 3′UTR of nephronectin over the full course of osteoblast development, including mineralization and nodule formation. The transfected cells were grown in parallel in nodule inducing conditions (regular growth medium supplemented with ascorbic acid, beta-glycerophosphate, and dexamethasone) over the three phases of bone development (proliferation, differentiation, and mineralization/nodule formation). ALP expression and nodule formation were analyzed on different days over the full course of osteogenesis. Consistent with the above results, the Npnt-transfected cells showed a significantly higher rate of differentiation as compared with the vector controls ( Fig. 3A ). The Npnt+3′-transfected cells exhibited a lower rate of differentiation than the Npnt-transfected cells during the early stages of osteogenesis until day 13. The rates of differentiation became similar between the Npnt- and Npnt+3′-transfected cells by day 17, and finally, during the later stages of osteogenesis (after day 27) the Npnt+3′-transfected cells displayed much higher levels of ALP activity than the Npnt-transfected cells. Photographs of the whole wells are provided in Supplementary ( Fig. S1A ). Statistical analysis indicated that all differences were significant ( Fig. 3B ). (A) Time course analysis showing the different effects of Npnt and Npnt+3′ transfection on MC3T3-E1 differentiation: early stages, Npnt>Npnt+3′; late stages, NpntNpnt+3′; late stages, Npnt